Home >> Research Area >>Natural Products>>Alkaloids>> Lycopsamine N-oxide

Lycopsamine N-oxide

CAS# 95462-15-0

Lycopsamine N-oxide

Catalog No. BCN8951----Order now to get a substantial discount!

Product Name & Size Price Stock
Lycopsamine N-oxide: 5mg Please Inquire In Stock
Lycopsamine N-oxide: 10mg Please Inquire In Stock
Lycopsamine N-oxide: 20mg Please Inquire Please Inquire
Lycopsamine N-oxide: 50mg Please Inquire Please Inquire
Lycopsamine N-oxide: 100mg Please Inquire Please Inquire
Lycopsamine N-oxide: 200mg Please Inquire Please Inquire
Lycopsamine N-oxide: 500mg Please Inquire Please Inquire
Lycopsamine N-oxide: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Lycopsamine N-oxide

Number of papers citing our products

Chemical structure

Lycopsamine N-oxide

3D structure

Chemical Properties of Lycopsamine N-oxide

Cas No. 95462-15-0 SDF Download SDF
PubChem ID 340067 Appearance White powder
Formula C15H25NO6 M.Wt 315.4
Type of Compound Alkaloids Storage Desiccate at -20°C
Solubility Soluble in methan
Chemical Name [(7R,8R)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate
SMILES CC(C)C(C(C)O)(C(=O)OCC1=CC[N+]2(C1C(CC2)O)[O-])O
Standard InChIKey DNAWGBOKUFFVMB-FVZLBROTSA-N
Standard InChI InChI=1S/C15H25NO6/c1-9(2)15(20,10(3)17)14(19)22-8-11-4-6-16(21)7-5-12(18)13(11)16/h4,9-10,12-13,17-18,20H,5-8H2,1-3H3/t10-,12+,13+,15-,16?/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Lycopsamine N-oxide

1 Amsinckia sp. 2 Anchusa sp. 3 Borago sp. 4 Cryptantha sp. 5 Eupatorium sp. 6 Heliotropium sp. 7 Messerschmidia sp. 8 Symphytum sp.

Lycopsamine N-oxide Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Lycopsamine N-oxide Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Lycopsamine N-oxide

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.1706 mL 15.8529 mL 31.7058 mL 63.4115 mL 79.2644 mL
5 mM 0.6341 mL 3.1706 mL 6.3412 mL 12.6823 mL 15.8529 mL
10 mM 0.3171 mL 1.5853 mL 3.1706 mL 6.3412 mL 7.9264 mL
50 mM 0.0634 mL 0.3171 mL 0.6341 mL 1.2682 mL 1.5853 mL
100 mM 0.0317 mL 0.1585 mL 0.3171 mL 0.6341 mL 0.7926 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Lycopsamine N-oxide

Absorption difference between hepatotoxic pyrrolizidine alkaloids and their N-oxides - Mechanism and its potential toxic impact.[Pubmed:31759111]

J Ethnopharmacol. 2020 Mar 1;249:112421.

ETHNOPHARMACOLOGICAL RELEVANCE: Pyrrolizidine alkaloids (PAs) are a group of phytotoxins widely present in about 3% of flowering plants. Many PA-containing herbal plants can cause liver injury. Our previous studies demonstrated that PA N-oxides are also hepatotoxic, with toxic potency much lower than the corresponding PAs, due to significant differences in their toxicokinetic fates. AIM OF STUDY: This study aimed to investigate the oral absorption of PAs and PA N-oxides for better understanding of their significant differences in toxicokinetics and toxic potency. MATERIALS AND METHODS: The oral absorption of PAs and PA N-oxides in rats and in rat in situ single pass intestine perfusion model was investigated. The intestinal permeability and absorption mechanisms of five pairs of PAs and PA N-oxides were evaluated by using Caco-2 monolayer model. RESULTS: The plasma concentrations of total PAs and PA N-oxides within 0-60 min were significantly lower in rats orally treated with a PA N-oxide-containing herbal alkaloid extract than with a PA-containing herbal alkaloid extract at the same dose, indicating that the absorption of PA N-oxides was lower than that of PAs. Using the rat in situ single pass intestine perfusion model, less cumulative amounts of retrorsine N-oxide in mesenteric blood were observed compared to that of retrorsine. In Caco-2 monolayer model, all five PAs showed absorption with Papp AtoB values [(1.43-16.26) x 10(-6) cm/s] higher than those of corresponding N-oxides with Papp AtoB values lower than 1.35 x 10(-6) cm/s. A further mechanistic study demonstrated that except for senecionine N-oxide, retrorsine N-oxide, and Lycopsamine N-oxide, all PAs and PA N-oxides investigated were absorbed via passive diffusion. While, for these 3 PA N-oxides, in addition to passive diffusion as their primary transportation, efflux transporter-mediated active transportation was also involved but to a less extent with the efflux ratio of 2.31-3.41. Furthermore, a good correlation between lipophilicity and permeability of retronecine-type PAs and their N-oxides with absorption via passive diffusion was observed, demonstrating that PAs have a better oral absorbability than that of the corresponding PA N-oxides. CONCLUSION: We discovered that among many contributors, the lower intestinal absorption of PA N-oxides was the initiating contributor that caused differences in toxicokinetics and toxic potency between PAs and PA N-oxides.

Keywords:

Lycopsamine N-oxide,95462-15-0,Natural Products, buy Lycopsamine N-oxide , Lycopsamine N-oxide supplier , purchase Lycopsamine N-oxide , Lycopsamine N-oxide cost , Lycopsamine N-oxide manufacturer , order Lycopsamine N-oxide , high purity Lycopsamine N-oxide

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: